Endava in Focus as BofA Initiates Coverage
Accenture's Balanced Risk/Reward Profile and Modest Revenue Growth Lead to Hold Rating
BNP Paribas Downgrades Accenture(ACN.US) to Hold Rating, Cuts Target Price to $375
BNP Paribas Exane Downgrades Accenture to Neutral, Price Target Is $375
Cautious Outlook on Accenture: Hold Rating Amid Modest Growth and Valuation Concerns
Baird Maintains Accenture(ACN.US) With Hold Rating, Maintains Target Price $370
Accenture (ACN) Receives a Hold From Jefferies
Guggenheim Adjusts Price Target on Accenture to $345 From $395, Maintains Buy Rating
DBS Maintains Accenture(ACN.US) With Hold Rating, Raises Target Price to $360
Accenture Hold Rating: Balancing AI Growth Potential With Macroeconomic Challenges
Barclays Maintains Overweight on Accenture, Raises Price Target to $415
DA Davidson Raises Price Target on Accenture to $372 From $339, Keeps Buy/Add Rating
Barclays Maintains Accenture(ACN.US) With Buy Rating, Maintains Target Price $415
TD Cowen Upgrades Accenture(ACN.US) to Buy Rating, Raises Target Price to $400
Accenture: Poised for Growth With Buy Rating Amid Sector Recovery and Strategic Positioning
A Quick Look at Today's Ratings for Accenture(ACN.US), With a Forecast Between $360 to $415
Accenture Is Maintained at Buy by UBS
Mizuho Securities Adjusts Accenture Price Target to $395 From $365
A Quick Look at Today's Ratings for Accenture(ACN.US), With a Forecast Between $350 to $395
Accenture Is Maintained at Buy by B of A Securities